Home > Drug Search >
  • company_query: Alizyme
  •   > 
Drug Filter
Category:
chemistry (15) biology (2)
Status:
Approved (1) Phase Ⅲ (3) Phase Ⅱ (10) Phase Ⅰ (3)
Clinical Stage:
Pending (4) Active (7) Discontinued (5)
Bio-Type:
Vaccine (1) Whole antibody (1)
Indication:
Acute myeloid Leukemia (AML) (1) Alzheimer's disease (AD) (2) Amyotrophic lateral sclerosis (ALS) (1) Arthritis (1) Breast cancer (1) Cushing's disease (1) Depression (1) Pancreatitis (1) HCV infection (1) HIV infection (1) Irritable bowel syndrome (IBS) (1) Malignancies (1) Non small cell lung cancer (NSCLC) (1) Ovarian cancer (1) Parkinson's disease (PD) (1) Small cell lung cancer (SCLC) (1) Solid tumours (2) Ulcerative colitis (2) Head and neck cancer (1) Nasopharyngeal cancer (1) Colorectal cancer (1) Stroke (1) Sarcoma (1) Diabetes (1) Renal carcinoma (1) Acute ischemic stroke (AIS) (1) Chemotherapy-radiotherapy induced mucositis (1) Glioma (1) Allergic asthma (1) Alopecia (1) Coronary restenosis (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top